Fármacos de uso frecuente en dermatología como terapia para COVID-19

Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortega-Peña, M., González-Cuevas, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AEDV. Published by Elsevier España, S.L.U. 2021
Materias:
Revisión
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546972/
https://www.ncbi.nlm.nih.gov/pubmed/33045209
http://dx.doi.org/10.1016/j.ad.2020.09.004
_version_ 1783592334152171520
author Ortega-Peña, M.
González-Cuevas, R.
author_facet Ortega-Peña, M.
González-Cuevas, R.
author_sort Ortega-Peña, M.
collection PubMed
description Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19.
format Online
Article
Text
id pubmed-7546972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AEDV. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-75469722020-10-13 Fármacos de uso frecuente en dermatología como terapia para COVID-19 Ortega-Peña, M. González-Cuevas, R. Actas Dermosifiliogr Revisión Researchers the world over are working to find the treatments needed to reduce the negative effects of coronavirus disease 2019 (COVID-19) and improve the current prognosis of patients. Several drugs that are often used in dermatology are among the potentially useful treatments: ivermectin, antiandrogenic agents, melatonin, and the antimalarial drugs chloroquine and hydroxychloroquine. These and other agents, some of which have proven controversial, are being scrutinized by the scientific community. We briefly review the aforementioned dermatologic drugs and describe the most recent findings relevant to their use against COVID-19. AEDV. Published by Elsevier España, S.L.U. 2021-02 2020-10-10 /pmc/articles/PMC7546972/ /pubmed/33045209 http://dx.doi.org/10.1016/j.ad.2020.09.004 Text en © 2020 AEDV. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Revisión
Ortega-Peña, M.
González-Cuevas, R.
Fármacos de uso frecuente en dermatología como terapia para COVID-19
title Fármacos de uso frecuente en dermatología como terapia para COVID-19
title_full Fármacos de uso frecuente en dermatología como terapia para COVID-19
title_fullStr Fármacos de uso frecuente en dermatología como terapia para COVID-19
title_full_unstemmed Fármacos de uso frecuente en dermatología como terapia para COVID-19
title_short Fármacos de uso frecuente en dermatología como terapia para COVID-19
title_sort fármacos de uso frecuente en dermatología como terapia para covid-19
topic Revisión
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546972/
https://www.ncbi.nlm.nih.gov/pubmed/33045209
http://dx.doi.org/10.1016/j.ad.2020.09.004
work_keys_str_mv AT ortegapenam farmacosdeusofrecuenteendermatologiacomoterapiaparacovid19
AT gonzalezcuevasr farmacosdeusofrecuenteendermatologiacomoterapiaparacovid19

Ejemplares similares